• Airway
  • Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask. (acpjc.org)
  • In patients with acute hypoxemic nonhypercapnic respiratory insufficiency caused primarily by acute lung injury, is treatment with continuous positive airway pressure (CPAP) delivered by a face mask as safe and effective as standard oxygen alone for improving clinical outcomes? (acpjc.org)
  • Despite some early improvement in oxygenation and symptoms, continuous positive airway pressure was no more effective than standard oxygen therapy for the eventual need for intubation, duration of ventilation, length of hospital stay, or mortality in patients with acute hypoxemic nonhypercapnic respiratory insufficiency primarily caused by acute lung injury. (acpjc.org)
  • patients
  • 90%. 61 patients received no additional respiratory interventions, and 62 received CPAP for 6 to 12 h/d until they no longer required it or they needed intubation and mechanical ventilation. (acpjc.org)
  • Patients with acute hypoxemic nonhyercapnic respiratory insufficiency may benefit from maintaining CPAP as continuously as possible, given the potential for rapid deterioration after the decrease or removal of positive end-expiratory pressure. (acpjc.org)
  • oxygen
  • The Breathe NIOV™ System will reduce the work of breathing in subjects with chronic respiratory insufficiency who require long-term oxygen therapy (LTOT). (clinicaltrials.gov)
  • The groups did not differ for any other outcomes at any time point: respiratory indices, need for intubation (34% in the CPAP group vs 39% in the oxygen group, P = 0.5), median duration of ventilation, median ICU stay (6.5 vs 6.0 d, P = 0.4), ICU mortality (21% vs 26%, P = 0.6), and hospital mortality (31% vs 30%, P = 0.9). (acpjc.org)